Quantitation of alfuzosin hydrochloride in pharmaceutical formulations by RP-HPLC

Pakistan Journal of Pharmaceutical Sciences

Volumn 22, Issue 3, 2009, Pages 263-266

  Ganesh, Mani ^a   Uppatyay, Satish ^a   Tivari, Rishi ^a   Kamalakannan, Kaliappan ^a   Rathinavel, Govindasamy ^a   Gangully, Swastika ^b   Sivakumar, Thangavel ^a  

^a NANDHA COLLEGE OF PHARMACY   (India)

^b BIRLA INSTITUTE OF TECHNOLOGY   (India)

Author keywords

Alfuzosin; Dosage formulation; Method validation; RP HPLC; UV detection

Indexed keywords

ALFUZOSIN; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; QUINAZOLINE DERIVATIVE;

ACCURACY; ARTICLE; DRUG FORMULATION; DRUG STABILITY; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; TEMPERATURE MEASUREMENT; ULTRAVIOLET RADIATION; CHEMISTRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SENSITIVITY AND SPECIFICITY; TABLET;

ADRENERGIC ALPHA-ANTAGONISTS; CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; QUINAZOLINES; SENSITIVITY AND SPECIFICITY; TABLETS;

EID: 68549119021     PISSN: 1011601X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. British Pharmacopoeia (2003). The Stationary office under license from the controller of Her Majesty's Stationary Office for the Department of Health on behalf of the Health Ministers. Vol.I, p.73.
2. Guine Bault P, Colafranceschi C and Thénot JP, (1986). High performance liquid chromatographic determination of alfuzosin HCl biological fluids.. J. Chromatogr A., 353: 361-369.
3. International Conference on the Harmonization of Technical Requirements for the Registration of Pharmaceuticals for Human Use (ICH) Q2B (1996). Validation of Analytical Procedures, Methodology, pp.1-8.
4. Jardin A, Bensadoun H, Delauche-Cavallier MC and Attali P. (1991). Alfuzosin for treatment of benign prostatic hypertrophy. Lancet., 337: 1457-1461.
5. Martindale, The Extra Pharmacopoeia (2005). Thirtyfourth Edition. Royal Pharmaceutical Society of Great Britain, 1 Lambeth High Street London SE17 Jn England, p.856.
6. th Ed., Merck Research Laboratories, Division of Merck & Co Inc., Whitehouse Station, NJ, p.235.
7. Rouchouse A and Manoha M (1990). Direct high performance chromatographic determination of the enantiomers of alfuzosin HCl in plasma. J. Chromatogr., 506: 601-610.
8. Teillac P, Delauche-Cavallier MC and Attali P(1992). Urinary flow rates in patients with benign prostatic hypertrophy following treatment with alfuzosin. Br. J. Urol., 70: 58-64.
9. Vamsi Krishna M and Gowri Sankar D (2007). New Diazo Coupling Reactions for Visible Spectrophotometric Determination of Alfuzosin in Pharmaceutical Preparations. E-Journal of Chemistry, 4: 496-501.